FDA: Hospira recalls another lot of Propofol

Editor's Note

The Food and Drug Administration (FDA) on August 22 posted the Hospira Inc (a Pfizer company) recall of one lot of Propofol Injectable Emulsion (containing Benzyl alcohol), 100 mL single patient use glass fliptop vials, lot EA7470.

The recall was initiated because of visible particulates observed in two vials during annual examination of retention samples.

On July 13, the FDA posted a nationwide recall by Hospira of the lot DX9067 of Propofol Injectable Emulsion, also containing Benzyl alcohol, 100 mL single patient use glass fliptop vial, OR Manager reported.

To date, Pfizer has not received any reports of adverse events associated with this issue. Distribution dates were July 16 through July 24, 2020. The expiration date is June 1, 2023.